Your browser doesn't support javascript.
loading
Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5.
Kamoun, Aurélie; de Reyniès, Aurélien; Allory, Yves; Sjödahl, Gottfrid; Robertson, A Gordon; Seiler, Roland; Hoadley, Katherine A; Groeneveld, Clarice S; Al-Ahmadie, Hikmat; Choi, Woonyoung; Castro, Mauro A A; Fontugne, Jacqueline; Eriksson, Pontus; Mo, Qianxing; Kardos, Jordan; Zlotta, Alexandre; Hartmann, Arndt; Dinney, Colin P; Bellmunt, Joaquim; Powles, Thomas; Malats, Núria; Chan, Keith S; Kim, William Y; McConkey, David J; Black, Peter C; Dyrskjøt, Lars; Höglund, Mattias; Lerner, Seth P; Real, Francisco X; Radvanyi, François; Aine, Mattias; Bernard-Pierrot, Isabelle; Czerniak, Bogdan; Gibb, Ewan A; Kim, Jaegil; Kwiatkowski, David J; Lebret, Thierry; Liedberg, Fredrik; Siefker-Radtke, A Arlene; Sirab, Nanor; Taber, Ann; Weinstein, John N.
Afiliação
  • Kamoun A; Cartes d'Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, France. Electronic address: aurelie.kamoun@ponts.org.
  • de Reyniès A; Cartes d'Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, France.
  • Allory Y; Department of Pathology, Institut Curie, Saint-Cloud, France; Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue Contre le Cancer, Paris, France.
  • Sjödahl G; Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Robertson AG; Canada's Michael Smith Genome Sciences Center, BC Cancer Agency, Vancouver, BC, Canada.
  • Seiler R; Department of Urology, Bern University Hospital, Bern, Switzerland.
  • Hoadley KA; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Groeneveld CS; Cartes d'Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, France; Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue Contre le Cancer, Paris, France; Bioinformatics and Systems Biology Laboratory, Federal University of Paraná, Polytechnic Cente
  • Al-Ahmadie H; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Choi W; Johns Hopkins Greenberg Bladder Cancer Institute and Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
  • Castro MAA; Bioinformatics and Systems Biology Laboratory, Federal University of Paraná, Polytechnic Center, Curitiba, Brazil.
  • Fontugne J; Department of Pathology, Institut Curie, Saint-Cloud, France; Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue Contre le Cancer, Paris, France.
  • Eriksson P; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Mo Q; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Kardos J; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Zlotta A; Division of Urology, Department of Surgery, University of Toronto, Mount Sinai Hospital and University Health Network, Toronto, ON, Canada.
  • Hartmann A; Institute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany.
  • Dinney CP; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bellmunt J; Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Powles T; Barts Cancer Institute ECMC, Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London, UK.
  • Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), CIBERONC, Madrid, Spain.
  • Chan KS; Cedars-Sinai Samuel Oschin Cancer Institute, Los Angeles, CA, USA.
  • Kim WY; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • McConkey DJ; Johns Hopkins Greenberg Bladder Cancer Institute and Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
  • Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Höglund M; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Lerner SP; Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Real FX; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO), CIBERONC, Madrid, Spain.
  • Radvanyi F; Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue Contre le Cancer, Paris, France.
  • Aine M; Division of Molecular Hematology, Department of Laboratory Medicine, Faculty of Medicine, Lund University, Lund, Sweden.
  • Bernard-Pierrot I; Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue Contre le Cancer, Paris, France.
  • Czerniak B; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gibb EA; GenomeDx Biosciences Inc., Vancouver, BC, Canada.
  • Kim J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Kwiatkowski DJ; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Lebret T; Department of Urology, University of Versailles-Saint-Quentin-en-Yvelines, Foch Hospital, Suresnes, France.
  • Liedberg F; Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Siefker-Radtke AA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sirab N; Department of Pathology, Institut Curie Hospital Group, Paris, France.
  • Taber A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Weinstein JN; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Eur Urol ; 77(4): 436-438, 2020 04.
Article em En | MEDLINE | ID: mdl-32037144
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Idioma: En Ano de publicação: 2020 Tipo de documento: Article